-

MedAvail Introduces New Compliance Packaging Solutions

Compliance Packaging Provides Convenience for Patients with Long-Term, Daily Medications

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that SpotRx has launched its compliance packaging solutions, allowing chronic care patients to receive more innovative and efficient pharmacy care from their homes.

The company is currently working with clinic partners to identify current patients or patients who could potentially benefit from its compliance packaging solutions. Medicare patients utilizing compliance packaging can take advantage of the following features:

  • One-month supply of medications organized by date and time
  • Home delivery, free of charge
  • Elimination of the need to manage multiple medications with separate packaging

“With compliance packaging, we are expanding the breadth of our solutions that make it easier for patients to not only start their medications but also stay on their medications,” said Neil Prezioso, Chief Pharmacy Officer. “We view compliance packaging as an important growth opportunity within our enterprise customers. We are excited to be providing long term medications labeled by each day and dose to chronic care patients right at their doorsteps, which is critical for medication adherence.”

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings Inc.

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com

MedAvail Holdings Inc.

NASDAQ:MDVL

Release Versions

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com

More News From MedAvail Holdings Inc.

MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the third quarter of 2022 on Thursday, November 10, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The conference call can be accessed by registering online for the live audio webcast on...

MedAvail Announces Technology Partnership with Progressive Care, Inc

MIAMI & MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-based retail pharmacy company, and Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care”) a personalized healthcare services and technology company, are excited to announce a technology agreement to deploy five MedAvail MedCenters in Florida. MedAvail MedCenter’s unique medication dispensing technology will allow PharmcoRx, a subsidiary of Progressive Care, to provide phar...

MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York. MedAvail’s management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Invest...
Back to Newsroom